Waste Management
Compare Stocks
2 / 10Stock Comparison
AWX vs USPH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
AWX vs USPH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Waste Management | Medical - Care Facilities |
| Market Cap | $10M | $897M |
| Revenue (TTM) | $85M | $695M |
| Net Income (TTM) | $585K | $11M |
| Gross Margin | 15.3% | 22.0% |
| Operating Margin | 3.7% | 12.2% |
| Forward P/E | 30.7x | 20.6x |
| Total Debt | $35M | $426M |
| Cash & Equiv. | $4M | $36M |
AWX vs USPH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avalon Holdings Cor… (AWX) | 100 | 184.7 | +84.7% |
| U.S. Physical Thera… (USPH) | 100 | 79.6 | -20.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AWX vs USPH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AWX is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 29.1% 10Y total return vs USPH's 22.6%
- Lower volatility, beta -0.12, Low D/E 94.3%, current ratio 1.01x
- Beta -0.12, current ratio 1.01x
USPH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.93, yield 3.1%
- Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
- 16.3% revenue growth vs AWX's -0.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.3% revenue growth vs AWX's -0.3% | |
| Value | Lower P/E (20.6x vs 30.7x) | |
| Quality / Margins | 1.5% margin vs AWX's 0.7% | |
| Stability / Safety | Lower D/E ratio (55.3% vs 94.3%) | |
| Dividends | 3.1% yield; 5-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -7.0% vs USPH's -14.3% | |
| Efficiency (ROA) | 0.9% ROA vs AWX's 0.7%, ROIC 5.6% vs 2.2% |
AWX vs USPH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AWX vs USPH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
USPH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
USPH is the larger business by revenue, generating $695M annually — 8.2x AWX's $85M. Profitability is closely matched — net margins range from 1.5% (USPH) to 0.7% (AWX).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $85M | $695M |
| EBITDAEarnings before interest/tax | $5M | $107M |
| Net IncomeAfter-tax profit | $585,000 | $11M |
| Free Cash FlowCash after capex | $3M | $67M |
| Gross MarginGross profit ÷ Revenue | +15.3% | +22.0% |
| Operating MarginEBIT ÷ Revenue | +3.7% | +12.2% |
| Net MarginNet income ÷ Revenue | +0.7% | +1.5% |
| FCF MarginFCF ÷ Revenue | +4.0% | +9.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.9% | +7.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +15.8% | -115.0% |
Valuation Metrics
AWX leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 30.7x trailing earnings, AWX trades at a 26% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, AWX's 7.0x EV/EBITDA is more attractive than USPH's 12.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $10M | $897M |
| Enterprise ValueMkt cap + debt − cash | $41M | $1.3B |
| Trailing P/EPrice ÷ TTM EPS | 30.74x | 41.55x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.63x |
| PEG RatioP/E ÷ EPS growth rate | 0.35x | — |
| EV / EBITDAEnterprise value multiple | 6.97x | 12.52x |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 1.15x |
| Price / BookPrice ÷ Book value/share | 0.27x | 1.16x |
| Price / FCFMarket cap ÷ FCF | 4.80x | 14.71x |
Profitability & Efficiency
USPH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
AWX delivers a 1.6% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $1 for USPH. USPH carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to AWX's 0.94x. On the Piotroski fundamental quality scale (0–9), AWX scores 6/9 vs USPH's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +1.6% | +1.4% |
| ROA (TTM)Return on assets | +0.7% | +0.9% |
| ROICReturn on invested capital | +2.2% | +5.6% |
| ROCEReturn on capital employed | +2.8% | +7.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.94x | 0.55x |
| Net DebtTotal debt minus cash | $31M | $390M |
| Cash & Equiv.Liquid assets | $4M | $36M |
| Total DebtShort + long-term debt | $35M | $426M |
| Interest CoverageEBIT ÷ Interest expense | 3.09x | 15.42x |
Total Returns (Dividends Reinvested)
AWX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in USPH five years ago would be worth $5,664 today (with dividends reinvested), compared to $5,610 for AWX. Over the past 12 months, AWX leads with a -7.0% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors AWX at -1.8% vs USPH's -17.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.0% | -24.6% |
| 1-Year ReturnPast 12 months | -7.0% | -14.3% |
| 3-Year ReturnCumulative with dividends | -5.2% | -43.7% |
| 5-Year ReturnCumulative with dividends | -43.9% | -43.4% |
| 10-Year ReturnCumulative with dividends | +29.1% | +22.6% |
| CAGR (3Y)Annualised 3-year return | -1.8% | -17.4% |
Risk & Volatility
Evenly matched — AWX and USPH each lead in 1 of 2 comparable metrics.
Risk & Volatility
AWX is the less volatile stock with a -0.12 beta — it tends to amplify market swings less than USPH's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. USPH currently trades 63.1% from its 52-week high vs AWX's 46.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.12x | 0.93x |
| 52-Week HighHighest price in past year | $5.43 | $93.50 |
| 52-Week LowLowest price in past year | $2.10 | $58.55 |
| % of 52W HighCurrent price vs 52-week peak | +46.6% | +63.1% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 46.1 |
| Avg Volume (50D)Average daily shares traded | 5K | 171K |
Analyst Outlook
USPH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
USPH is the only dividend payer here at 3.06% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $102.00 |
| # AnalystsCovering analysts | — | 12 |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% |
| Dividend StreakConsecutive years of raises | 1 | 5 |
| Dividend / ShareAnnual DPS | — | $1.80 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.6% |
USPH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AWX leads in 2 (Valuation Metrics, Total Returns). 1 tied.
AWX vs USPH: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is AWX or USPH a better buy right now?
For growth investors, U.
S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -0. 3% for Avalon Holdings Corporation (AWX). Avalon Holdings Corporation (AWX) offers the better valuation at 30. 7x trailing P/E, making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AWX or USPH?
On trailing P/E, Avalon Holdings Corporation (AWX) is the cheapest at 30.
7x versus U. S. Physical Therapy, Inc. at 41. 5x.
03Which is the better long-term investment — AWX or USPH?
Over the past 5 years, U.
S. Physical Therapy, Inc. (USPH) delivered a total return of -43. 4%, compared to -43. 9% for Avalon Holdings Corporation (AWX). Over 10 years, the gap is even starker: AWX returned +29. 1% versus USPH's +22. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AWX or USPH?
By beta (market sensitivity over 5 years), Avalon Holdings Corporation (AWX) is the lower-risk stock at -0.
12β versus U. S. Physical Therapy, Inc. 's 0. 93β — meaning USPH is approximately -873% more volatile than AWX relative to the S&P 500. On balance sheet safety, U. S. Physical Therapy, Inc. (USPH) carries a lower debt/equity ratio of 55% versus 94% for Avalon Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — AWX or USPH?
By revenue growth (latest reported year), U.
S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -0. 3% for Avalon Holdings Corporation (AWX). On earnings-per-share growth, the picture is similar: U. S. Physical Therapy, Inc. grew EPS -22. 8% year-over-year, compared to -75. 8% for Avalon Holdings Corporation. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AWX or USPH?
U.
S. Physical Therapy, Inc. (USPH) is the more profitable company, earning 1. 9% net margin versus 0. 4% for Avalon Holdings Corporation — meaning it keeps 1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus 2. 4% for AWX. At the gross margin level — before operating expenses — USPH leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — AWX or USPH?
In this comparison, USPH (3.
1% yield) pays a dividend. AWX does not pay a meaningful dividend and should not be held primarily for income.
08Is AWX or USPH better for a retirement portfolio?
For long-horizon retirement investors, Avalon Holdings Corporation (AWX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
12)). Both have compounded well over 10 years (AWX: +29. 1%, USPH: +22. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AWX and USPH?
These companies operate in different sectors (AWX (Industrials) and USPH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AWX is a small-cap quality compounder stock; USPH is a small-cap high-growth stock. USPH pays a dividend while AWX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.